PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2007 June; 8(2): E134.
Published online 2007 June 22. doi:  10.1208/pt0802047
PMCID: PMC2750362

PEGylated rosin derivatives: Novel microencapsulating materials for sustained drug delivery

Abstract

The aim of this study was to investigate PEGylated rosin derivatives (PRDs) as microencapsulating materials for sustained drug delivery. PRDs (D1, D2, and D3) composed of a constant weight of rosin and varied amounts of polyethylene glycol (PEG) 400 and maleic anhydride were synthesized in the laboratory. Microparticles were prepared by the O/O solvent evaporation technique using the acetone/paraffin system. Diclofenac sodium (DFS) and diltiazem hydrochloride (DLTZ) were used as model drugs. The effect of the type of PRD, drug, PRD:drug ratio, viscosity of external phase, stirring speed, concentration of magnesium stearate (droplet stabilizer), and method of preparation on particle size, drug loading, and drug release profiles of microparticles was investigated. PRDs could produce discrete and spherical microspheres (with DFS) and microcapsules (with DLTZ). The drug loading value for microparticles was found to be in the range of 37.21% to 87.90%. The microparticle size range was 14 to 36 μm. The particle size and drug loadings of microparticles were substantially affected by the concentration of magnesium stearate and the type of drug, respectively. Most of the formulations could sustain the DFS and DLTZ release for 20 hours. DFS and DLTZ release from PRD microparticles followed Hixson-Crowell and first-order kinetics, respectively. The results suggest that PRDs can be used successfully to prepare discrete and spherical microparticles with DFS and DLTZ for sustained drug delivery.

Keywords: PeGylated rosin derivatives, diclofenac sodium, diltiazem hydrochloride, microspheres, microcapsules, solvent evaporation, release kinetics

Full Text

The Full Text of this article is available as a PDF (666K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Satturwar PM, Fulzele SV, Dorle AK. Biodegradation and in vivo biocompatibility of rosin: a natural film-forming polymer. AAPS PharmSciTech. 2003;4:E55–E55. doi: 10.1208/pt040455. [PMC free article] [PubMed] [Cross Ref]
2. Reddy MN, Shirwaikar AA. Rosin, a polymer for microencapsulation of diltiazem hydrochloride for sustained release by emulsion-solvent evaporation technique. Ind J Pharm Sci. 2000;7:308–310.
3. Nande VS, Barabde UV, Morkhade DM, Patil AT, Joshi SB. Synthesis and characterization of PEGylated derivatives of rosin for sustained drug delivery.React Funct Polym. In press.
4. Puranik PK, Dorle AK. Study of abietic acid glycerol derivatives as microencapsulating materials. J Microencapsul. 1991;8:247–252. doi: 10.3109/02652049109071493. [PubMed] [Cross Ref]
5. Barabde UV, Fulzele SV, Satturwar PM, Dorle AK, Joshi SB. Film coating and biodegradation studies of new rosin derivative. React Funct Polym. 2005;62:241–248. doi: 10.1016/j.reactfunctpolym.2004.12.001. [Cross Ref]
6. Mishra PR, Mishra M, Namdeo A, Jain S, Jain NK. PEGylation: a novel approach in protein administration. Ind J Pharm Sci. 2002;64:413–422.
7. Berry GW. Rosin and rosin derivatives. In: Dukes EP, editor. Kirk-Othmer Encyclopedia of Chemical Technology. New York, NY: Intersciences Publishers; 1968. pp. 475–508.
8. Morkhade DM, Nande VS, Barabde UV, Patil AT, Joshi SB. PEGylated rosin derivatives: synthesis, characterization and evaluation as coating materials for sustained drug delivery. In:React Funct Polym. 2006.
9. Pathak YV, Dorle AK. Effect of pH on the release characteristics of pentaester gum microcapsules and a study of dissolution kinetics. J Microencapsul. 1986;3:127–129. doi: 10.3109/02652048609031567. [PubMed] [Cross Ref]
10. Mosqueira VCF, Legrand P, Gulik A, et al. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials. 2001;22:2967–2979. doi: 10.1016/S0142-9612(01)00043-6. [PubMed] [Cross Ref]
11. Morkhade DM, Fulzele SV, Satturwar PM, Joshi SB. Gum copal and gum damar: novel matrix forming materials for sustained drug delivery. Ind J Pharm Sci. 2006;68:53–58. doi: 10.4103/0250-474X.22964. [Cross Ref]
12. Nokhodchi A, Farid D. Microencapsulation of paracetamol by various emulsion techniques using cellulose acetate phthalate. Pharm Tech. 2002;26:54–60.
13. Fulzele SV, Satturwar PM, Kasliwal RH, Dorle AK. Preparation and evaluation of microcapsules using polymerized rosin as a novel wall forming material. J Microencapsul. 2004;21:83–89. doi: 10.1080/02652040410001653768. [PubMed] [Cross Ref]
14. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133. doi: 10.1016/S0928-0987(01)00095-1. [PubMed] [Cross Ref]
15. Kim BK, Hwang SJ, Park JB, Park HJ. Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul. 2002;19:811–822. doi: 10.1080/0265204021000022770. [PubMed] [Cross Ref]
16. Rippie EG. Mixing. In: Lachman L, Liberman HA, Kanig J, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Bombay, India: Varghese; 1990. pp. 3–20.
17. Mateovic T, Kriznar B, Bogataj M, Mrhar A. The influence of stirring rate on biopharmaceutical properties of Eudragit RS microspheres. J Microencapsul. 2002;19:29–36. doi: 10.1080/02652040010055289. [PubMed] [Cross Ref]
18. Sheorey DS, Sesha-Sai M, Dorle AK. A new technique for the encapsulation of water insoluble drugs using ethyl cellulose. J Microencapsul. 1991;8:359–368. doi: 10.3109/02652049109069562. [PubMed] [Cross Ref]
19. Huang YY, Chung TW, Tzeng TW. Drug release from PLA/PEG microparticulates. Int J Pharm. 1997;156:9–15. doi: 10.1016/S0378-5173(97)00154-3. [Cross Ref]
20. Guyot M, Fawaz F. Nifedipine loaded-polymeric microspheres: preparation and physical characteristics. Int J Pharm. 1998;175:61–74. doi: 10.1016/S0378-5173(98)00253-1. [Cross Ref]
21. Janjikhel RK, Adeyeye CM. Stereospecific formulation and characterization of ibuprofen microspheres. J Microencapsul. 1997;14:409–426. doi: 10.3109/02652049709033826. [PubMed] [Cross Ref]
22. Yang YY, Chung TS, Bai XL, Chang WK. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double emulsion method. Chem Eng Sci. 2000;55:2223–2236. doi: 10.1016/S0009-2509(99)00503-5. [Cross Ref]
23. Jeyanthi R, Thanoo BC, Metha RC, DeLuca PP. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J Control Release. 1996;38:235–244. doi: 10.1016/0168-3659(95)00125-5. [Cross Ref]
24. Niebergall PJ, Milosovich G, Goyan JE. Dissolution rate studies, II: dissolution of particles under condition of rapid agitation. J Pharm Sci. 1963;52:236–241. doi: 10.1002/jps.2600520310. [PubMed] [Cross Ref]
25. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123–133. doi: 10.1016/S0928-0987(01)00095-1. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists